speb/financial-data huggingface dataset:
Financial ratios for TRA.AX — annual report dated 2023-03-31
Total revenue: 244671069.18238991
Gross profit: 135245911.9496855
Operating income: 40798742.13836478
Net income: 20481761.006289307
Capital expenditures: 27191823.89937107
Depreciation & amortization: 7218867.924528302
Net tangible assets: 68361006.28930818
Owner earnings: 508805.03144653887
Return on net tangible assets (%): 0.7442913132279582
Capex to operating income (%): 66.64868197934331
Buffett classification: The Good
Stock price: 1.731543624161074
P/E ratio: 7.695345004754414
Shares outstanding: 91025265
Book value: 171226415.0943396
P/B ratio: 0.9205017646458485
Market cap (USD): 157614217.24832216
Debt to equity: 1.6130578512396694
Current ratio: 1.0874143294847802
Quick ratio: 1.0363023291395483
Effective tax rate (%): 28.49709078932924
Interest coverage ratio: 3.254402247529223
COGS to revenue (%): 44.72337395604933
SG&A to revenue (%): 16.873636020121996
Free cash flow (dilution-adjusted): 15182389.937106917
Buyback yield (%): 0
Retained earnings: 37869811.320754714
Inventory turnover: 6.677130905322946
Receivables turnover: 0.8827639258257468
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.960130239464082
FCF margin (%): 6.205224830153177
Revenue growth (%): 23.54288551784663
Rule of 40 score: 29.74811034799981
Financial ratios for TRA.AX — annual report dated 2024-03-31
Total revenue: 206259281.43712574
Gross profit: 100166467.06586827
Operating income: 2674251.497005988
Net income: 19740119.760479044
Capital expenditures: 9258083.83233533
Depreciation & amortization: 7166467.065868264
Net tangible assets: 68946107.78443114
Owner earnings: 17648502.994011976
Return on net tangible assets (%): 25.597533437554276
Capex to operating income (%): 346.19346171070316
Buffett classification: The Gruesome
Stock price: 2.5947712418300655
P/E ratio: 11.964959826374885
Shares outstanding: 91025265
Book value: 166601197.60479045
P/B ratio: 1.4176953305116542
Market cap (USD): 236189739.9019608
Debt to equity: 1.6182716084881246
Current ratio: 1.1539797894339112
Quick ratio: 1.1025375123466805
Effective tax rate (%): 32.912757687376626
Interest coverage ratio: 0.16040514330867034
COGS to revenue (%): 51.43662560639623
SG&A to revenue (%): 20.907061340734444
Free cash flow (dilution-adjusted): 6604790.419161677
Buyback yield (%): 0
Retained earnings: 38474251.49700599
Inventory turnover: 7.072571953215441
Receivables turnover: 0.7690502663576649
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1793443099145726
FCF margin (%): 3.2021785265333738
Revenue growth (%): -15.69935827461077
Rule of 40 score: -12.497179748077397
Financial ratios for TRA.AX — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 77238857.14285715
Buffett classification: The Gruesome
Stock price: 2.89937106918239
Shares outstanding: 91025265
Book value: 170567428.5714286
P/B ratio: 1.5472826325404805
Market cap (USD): 263916019.9056604
Debt to equity: 1.5684756426448858
Current ratio: 0.6374090494147192
Quick ratio: 0.5946752741517377
Buyback yield (%): 0
Retained earnings: 48353142.85714286
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TRA.AX — annual report dated 2025-03-31
Total revenue: 145989142.85714287
Gross profit: 50274285.71428572
Operating income: -43868000
Net income: 22049714.285714287
Capital expenditures: 15109142.857142856
Depreciation & amortization: 6657714.285714285
Net tangible assets: 77238857.14285715
Owner earnings: 13598285.714285718
Return on net tangible assets (%): 17.605498342803035
Buffett classification: The Gruesome
Stock price: 2.89937106918239
P/E ratio: 11.969135585427882
Shares outstanding: 91025265
Book value: 170567428.5714286
P/B ratio: 1.5472826325404805
Market cap (USD): 263916019.9056604
Debt to equity: 1.5684756426448858
Current ratio: 0.6374090494147192
Quick ratio: 0.5946752741517377
Effective tax rate (%): 28.90334230018056
Interest coverage ratio: -2.7965830024407126
COGS to revenue (%): 65.56299685690912
SG&A to revenue (%): 29.150112924248766
Free cash flow (dilution-adjusted): 607428.5714285715
Buyback yield (%): 0
Retained earnings: 48353142.85714286
Inventory turnover: 7.548830501599893
Receivables turnover: 1.2385396265198085
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.262848339163032
FCF margin (%): 0.4160779079461878
Revenue growth (%): -29.22057041993288
Rule of 40 score: -28.80449251198669
Financial ratios for VANTI.PA — annual report dated 2021-12-31
Gross profit: 312500000
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.1931818181818181
Shares outstanding: 490293903
Market cap (USD): 585009770.625
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VANTI.PA — annual report dated 2022-12-31
Total revenue: 2953191489.3617024
Operating income: 24468085.10638298
Net income: 160638297.87234044
Capital expenditures: 36170212.76595745
Operating cash flow: 91489361.70212767
Depreciation & amortization: 143617021.27659574
Net tangible assets: -491489361.7021277
Owner earnings: 268085106.3829787
Return on net tangible assets (%): -54.54545454545454
Capex to operating income (%): 147.82608695652175
Buffett classification: The Gruesome
Stock price: 0.22340425531914895
P/E ratio: 0.6818656929139073
Shares outstanding: 490293903
Book value: 340425531.9148936
P/B ratio: 0.32175537384374997
Market cap (USD): 109533744.28723405
Debt to equity: 1.346875
Current ratio: 0.9287257019438444
Quick ratio: 0.6033117350611951
Interest coverage ratio: 0.13372093023255816
COGS to revenue (%): 88.94092219020172
R&D to revenue (%): 3.2060518731988474
SG&A to revenue (%): 7.3847262247838605
Free cash flow (dilution-adjusted): 3191489.361702128
Buyback yield (%): 0
Retained earnings: -584042553.1914893
Inventory turnover: 5.462389380530973
Receivables turnover: 8.0932944606414
Capitalized R&D asset: 94680851.0638298
ROCI (R&D-adjusted, %): 7.893895813358902
FCF margin (%): 0.10806916426512966
Rule of 40 score: 0.10806916426512966
Financial ratios for VANTI.PA — annual report dated 2023-12-31
Total revenue: 1736666666.6666665
Gross profit: 230000000
Operating income: 18888888.888888888
Net income: -316666666.6666667
Capital expenditures: 17777777.777777776
Operating cash flow: -7777777.777777778
Depreciation & amortization: 88888888.88888888
Net tangible assets: -660000000
Owner earnings: -245555555.55555558
Capex to operating income (%): 94.11764705882352
Buffett classification: The Gruesome
Stock price: 0.13333333333333333
Shares outstanding: 490293903
Book value: 6666666.666666746
P/B ratio: 9.805878059999882
Market cap (USD): 65372520.4
Debt to equity: 90.33333333333225
Current ratio: 0.8446411012782694
Quick ratio: 0.6440511307767945
Interest coverage ratio: 0.2361111111111111
COGS to revenue (%): 86.75623800383877
R&D to revenue (%): 4.350607805502239
SG&A to revenue (%): 9.277031349968011
Free cash flow (dilution-adjusted): -74444444.44444445
Buyback yield (%): 1.6996608120850594
Retained earnings: -925555555.5555556
Inventory turnover: 6.647058823529412
Receivables turnover: 5.704379562043796
Capitalized R&D asset: 138991725.7683215
ROCI (R&D-adjusted, %): 4.3887472300849355
FCF margin (%): -4.286628278950736
Revenue growth (%): -41.19356388088378
Rule of 40 score: -45.480192159834516
Financial ratios for VANTI.PA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.12222222222222222
Shares outstanding: 490293903
Market cap (USD): 59924810.36666667
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VANTI.PA — annual report dated 2024-12-31
Total revenue: 1942708333.3333335
Operating income: 22916666.666666668
Net income: -293750000
Capital expenditures: 12500000
Operating cash flow: 37500000
Depreciation & amortization: 105208333.33333334
Net tangible assets: -902083333.3333334
Owner earnings: -201041666.66666666
Capex to operating income (%): 54.54545454545454
Buffett classification: The Good
Stock price: 0.125
Shares outstanding: 490293903
Book value: -247916666.66666675
Market cap (USD): 61286737.875
Debt to equity: -2.092436974789915
Current ratio: 0.7760956175298804
Quick ratio: 0.6310756972111553
Interest coverage ratio: 0.27499999999999997
COGS to revenue (%): 84.343163538874
R&D to revenue (%): 4.611260053619303
SG&A to revenue (%): 9.973190348525469
Free cash flow (dilution-adjusted): -39583333.333333336
Buyback yield (%): 0
Retained earnings: -1161458333.3333335
Inventory turnover: 8.642857142857142
Receivables turnover: 4.650872817955112
Capitalized R&D asset: 171450236.40661943
ROCI (R&D-adjusted, %): 3.9482195222670913
FCF margin (%): -2.037533512064343
Revenue growth (%): 11.864203454894454
Rule of 40 score: 9.826669942830112
Financial ratios for VANTI.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -902083333.3333334
Buffett classification: The Gruesome
Stock price: 0.125
Shares outstanding: 490293903
Book value: -247916666.66666675
Market cap (USD): 61286737.875
Debt to equity: -2.092436974789915
Current ratio: 0.7760956175298804
Quick ratio: 0.6310756972111553
Buyback yield (%): 0
Retained earnings: -1161458333.3333335
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VANTI.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -1100000000
Buffett classification: The Gruesome
Stock price: 0.17647058823529413
Shares outstanding: 490293903
Book value: -448235294.1176472
Market cap (USD): 86522453.47058824
Debt to equity: -1.21259842519685
Current ratio: 0.6377358490566037
Quick ratio: 0.44150943396226416
Buyback yield (%): 0
Retained earnings: -1658823529.4117649
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VIVT3.SA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.194736842105263
Shares outstanding: 3195606352
Market cap (USD): 10209121345.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VIVT3.SA — annual report dated 2022-12-31
Total revenue: 12833526893.939394
Gross profit: 3903310984.8484845
Operating income: 1208593939.3939393
Net income: 773676704.5454545
Capital expenditures: 1726537878.7878788
Operating cash flow: 3587485795.4545455
Depreciation & amortization: 2397703219.6969695
Net tangible assets: 3537592803.030303
Owner earnings: 1444842045.4545453
Return on net tangible assets (%): 40.84251992532587
Capex to operating income (%): 142.85508329238084
Buffett classification: The Gruesome
Stock price: 2.8614800759013286
P/E ratio: 11.8191020266586
Shares outstanding: 3195606352
Book value: 12965122537.878786
P/B ratio: 0.7052894317007973
Market cap (USD): 9144163906.671728
Debt to equity: 0.2819597864299305
Current ratio: 0.7795827108907604
Quick ratio: 0.7431055915189042
Effective tax rate (%): 16.013131078354935
Interest coverage ratio: 18.474037704386493
COGS to revenue (%): 40.482978547755664
SG&A to revenue (%): 17.74681910789362
Free cash flow (dilution-adjusted): 1713600189.3939393
Buyback yield (%): 1.2581360516004454
Inventory turnover: 33.91970561031946
Receivables turnover: 5.701512964856459
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.582079194157554
FCF margin (%): 13.352527357099186
Rule of 40 score: 13.352527357099186
Financial ratios for VIVT3.SA — annual report dated 2023-12-31
Total revenue: 14686505773.195877
Gross profit: 4677268247.422681
Operating income: 1609453814.4329898
Net income: 1039170515.4639176
Capital expenditures: 1727195876.2886598
Operating cash flow: 3873386804.1237116
Depreciation & amortization: 2760736701.030928
Net tangible assets: 4248210309.278351
Owner earnings: 2072711340.206186
Return on net tangible assets (%): 48.79022433704042
Capex to operating income (%): 107.31565334772594
Buffett classification: The Gruesome
Stock price: 4.6894409937888195
P/E ratio: 14.420739622689073
Shares outstanding: 3195606352
Book value: 14356148453.608246
P/B ratio: 1.0438459504306876
Market cap (USD): 14985607427.080744
Debt to equity: 0.2691073992220296
Current ratio: 0.9582147823381821
Quick ratio: 0.9146371592692041
Effective tax rate (%): 9.579243748919072
Interest coverage ratio: 13.934167566650897
COGS to revenue (%): 41.29662304633583
SG&A to revenue (%): 16.246169620073285
Free cash flow (dilution-adjusted): 2056614432.9896908
Buyback yield (%): 0.6724775478817951
Inventory turnover: 33.60911129874626
Receivables turnover: 5.93159898275312
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.755148151590826
FCF margin (%): 14.003429166542713
Revenue growth (%): 14.438578689787516
Rule of 40 score: 28.44200785633023
Financial ratios for VIVT3.SA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.539594843462247
Shares outstanding: 3195606352
Market cap (USD): 14506758117.274403
Buyback yield (%): 0
Retained earnings: 338292265.19337016
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VIVT3.SA — quarterly report dated 2024-12-31
Capital expenditures: 437504207.11974114
Operating cash flow: 739461003.236246
Depreciation & amortization: 608597249.1909386
Buffett classification: The Gruesome
Stock price: 3.3893376413570273
Shares outstanding: 3195606352
Market cap (USD): 10830988895.793215
Free cash flow (dilution-adjusted): 301956796.11650485
Buyback yield (%): 0.4869627396569962
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VIVT3.SA — annual report dated 2024-12-31
Total revenue: 12422720711.974112
Gross profit: 3963250809.0614886
Operating income: 1443123462.7831717
Net income: 899244660.1941748
Capital expenditures: 1447820711.9741101
Operating cash flow: 3216273139.158576
Depreciation & amortization: 2298104368.932039
Net tangible assets: 3473775889.9676375
Owner earnings: 1749528317.1521034
Return on net tangible assets (%): 50.36387989808987
Capex to operating income (%): 100.3254918454364
Buffett classification: The Gruesome
Stock price: 3.3893376413570273
P/E ratio: 12.044540685350823
Shares outstanding: 3195606352
Book value: 11294416666.666668
P/B ratio: 0.958968419126844
Market cap (USD): 10830988895.793215
Debt to equity: 0.2972303739446825
Current ratio: 0.9404890910146982
Quick ratio: 0.8924718212870433
Effective tax rate (%): 17.837242299420343
Interest coverage ratio: 15.450545624007109
COGS to revenue (%): 40.837791032596684
SG&A to revenue (%): 15.714658913812452
Free cash flow (dilution-adjusted): 1707515372.168285
Buyback yield (%): 4.12465960630553
Inventory turnover: 26.916344436813187
Receivables turnover: 6.0783935303920815
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.85802624310937
FCF margin (%): 13.745099900076085
Revenue growth (%): -15.414048080472387
Rule of 40 score: -1.6689481803963027
Financial ratios for VIVT3.SA — quarterly report dated 2025-03-31
Total revenue: 3439108159.7222223
Gross profit: 1103192881.9444444
Operating income: 376890972.2222222
Net income: 183717361.1111111
Capital expenditures: 411175694.4444445
Operating cash flow: 883826909.7222222
Depreciation & amortization: 644961111.1111112
Net tangible assets: 3490435937.5
Owner earnings: 417502777.77777785
Return on net tangible assets (%): 11.961336212828797
Capex to operating income (%): 109.09672153197857
Buffett classification: The Gruesome
Stock price: 3.9965277777777777
P/E ratio: 17.379045555862152
Shares outstanding: 3195606352
Book value: 11830612152.777779
P/B ratio: 1.0795155303618382
Market cap (USD): 12771329552.61111
Debt to equity: 0.30170362239696963
Current ratio: 0.9641091385471221
Quick ratio: 0.9153753878956309
Effective tax rate (%): 25.392542574005667
Interest coverage ratio: 2.9071318666161363
COGS to revenue (%): 40.56628457101105
SG&A to revenue (%): 16.13536556105091
Free cash flow (dilution-adjusted): 463459895.8333334
Buyback yield (%): 0.44380956353018153
Retained earnings: 116255208.33333334
Inventory turnover: 6.1624389383517
Receivables turnover: 1.578394756634106
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1742136984620988
FCF margin (%): 13.476165165761088
Rule of 40 score: 13.476165165761088
Financial ratios for VIVT3.SA — quarterly report dated 2025-06-30
Total revenue: 2672462043.7956204
Gross profit: 1207794708.029197
Operating income: 448307299.27007294
Net income: 245338321.1678832
Capital expenditures: 395794525.54744524
Depreciation & amortization: 673167883.2116787
Net tangible assets: 3711691240.875912
Owner earnings: 522711678.83211666
Return on net tangible assets (%): 14.08284377417027
Capex to operating income (%): 88.28643347807895
Buffett classification: The Gruesome
Stock price: 5.255474452554744
P/E ratio: 39.142769195251105
Shares outstanding: 3195606352
Book value: 12434248540.145983
P/B ratio: 1.3506588266379056
Market cap (USD): 16794427543.357664
Debt to equity: 0.29814770782170663
Current ratio: 0.9825858367725695
Quick ratio: 0.9455833327954816
Effective tax rate (%): 13.950946671381272
COGS to revenue (%): 54.80591723152028
SG&A to revenue (%): 21.779651503725614
Free cash flow (dilution-adjusted): 662261496.3503649
Buyback yield (%): 0.5163632713920704
Inventory turnover: 8.092566098116494
Receivables turnover: 1.1970625601643787
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.4648203680001957
FCF margin (%): 24.78095050546627
Revenue growth (%): -22.292003633538645
Rule of 40 score: 2.4889468719276238
Financial ratios for VIVT3.SA — quarterly report dated 2025-09-30
Total revenue: 3864470300.7518797
Gross profit: 1279115413.5338345
Operating income: 553405263.1578947
Net income: 354954699.2481203
Capital expenditures: 415656015.03759396
Operating cash flow: 866370676.6917293
Depreciation & amortization: 698921804.5112782
Net tangible assets: 3931417481.203007
Owner earnings: 638220488.7218045
Return on net tangible assets (%): 16.23385183011676
Capex to operating income (%): 75.10879326765657
Buffett classification: The Gruesome
Stock price: 6.026315789473684
P/E ratio: 24.5631097109828
Shares outstanding: 3195606352
Book value: 12876015789.473682
P/B ratio: 1.4956282541796395
Market cap (USD): 19257733016
Debt to equity: 0.26388993267835326
Current ratio: 1.0154681479772893
Quick ratio: 0.958049731077765
Effective tax rate (%): 10.229290570607825
Interest coverage ratio: 15.812682947789051
COGS to revenue (%): 39.61364429425542
SG&A to revenue (%): 15.517295554809085
Free cash flow (dilution-adjusted): 423517105.26315784
Buyback yield (%): 2.487313473356156
Retained earnings: 403906015.03759396
Inventory turnover: 5.9398009068518585
Receivables turnover: 1.5830095548904943
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9435265588065995
FCF margin (%): 10.959253721803929
Revenue growth (%): 44.603374619430866
Rule of 40 score: 55.5626283412348
Financial ratios for VIVT3.SA — quarterly report dated 2025-12-31
Total revenue: 3970382481.7518244
Gross profit: 1257597080.2919707
Operating income: 424370255.4744525
Net income: 345848175.1824817
Capital expenditures: 414671350.3649635
Operating cash flow: 938857481.7518247
Depreciation & amortization: 697482481.7518247
Net tangible assets: 3787095802.919708
Owner earnings: 628659306.5693429
Return on net tangible assets (%): 16.60003705437476
Capex to operating income (%): 97.71451816323801
Buffett classification: The Gruesome
Stock price: 5.646319569120287
P/E ratio: 15.969622545541625
Shares outstanding: 3195606352
Book value: 12591738321.167883
P/B ratio: 1.4329566117308867
Market cap (USD): 18043414680.502693
Debt to equity: 0.29486778536836356
Current ratio: 0.9989759229398452
Quick ratio: 0.9381941727583224
Effective tax rate (%): 13.752630314327114
Interest coverage ratio: 11.640025226614078
COGS to revenue (%): 40.07293327381723
SG&A to revenue (%): 15.127782831417443
Free cash flow (dilution-adjusted): 494162773.7226277
Buyback yield (%): 0.3480261581947886
Inventory turnover: 5.681928048458623
Receivables turnover: 1.5923951566446761
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2616448452928934
FCF margin (%): 12.446225923921357
Revenue growth (%): 2.740664897316928
Rule of 40 score: 15.186890821238286
Financial ratios for VIVT3.SA — annual report dated 2025-12-31
Total revenue: 15030149817.518248
Gross profit: 4866721167.883211
Operating income: 1806073175.1824815
Net income: 1127288868.6131387
Capital expenditures: 1646170620.437956
Operating cash flow: 3780547810.218978
Depreciation & amortization: 2727081021.89781
Net tangible assets: 3787095802.919708
Owner earnings: 2208199270.0729923
Return on net tangible assets (%): 58.308513567852025
Capex to operating income (%): 91.14639667197486
Buffett classification: The Gruesome
Stock price: 5.646319569120287
P/E ratio: 16.006025769331718
Shares outstanding: 3195606352
Book value: 12591738321.167883
P/B ratio: 1.4329566117308867
Market cap (USD): 18043414680.502693
Debt to equity: 0.29486778536836356
Current ratio: 0.9989759229398452
Quick ratio: 0.9381941727583224
Effective tax rate (%): 15.037939370450298
Interest coverage ratio: 12.483909621936345
COGS to revenue (%): 39.97484326546031
SG&A to revenue (%): 15.622615764000683
Free cash flow (dilution-adjusted): 2054716240.8759122
Buyback yield (%): 3.736029522164106
Inventory turnover: 21.456670392080834
Receivables turnover: 6.028118923822098
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.625311939703396
FCF margin (%): 13.670630471567605
Revenue growth (%): 20.989195249562894
Rule of 40 score: 34.6598257211305
Financial ratios for WEX.V — annual report dated 2021-12-31
Capital expenditures: 34514.96062992126
Depreciation & amortization: 9870.866141732284
Buffett classification: The Gruesome
Stock price: 7.874015748031496
Shares outstanding: 62427269
Market cap (USD): 491553299.21259844
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WEX.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -7772.794117647059
Operating income: -4125109.558823529
Net income: -3958628.676470588
Capital expenditures: 7352.941176470587
Operating cash flow: -3739412.4999999995
Depreciation & amortization: 7772.794117647059
Net tangible assets: 6552552.94117647
Owner earnings: -3958208.823529411
Return on net tangible assets (%): -60.4071246590911
Buffett classification: The Gruesome
Stock price: 0.9558823529411764
Shares outstanding: 62427269
Book value: 6552552.94117647
P/B ratio: 9.106851225027693
Market cap (USD): 59673124.77941176
Debt to equity: 0
Current ratio: 11.24694988930724
Quick ratio: 11.24694988930724
Free cash flow (dilution-adjusted): -4822230.147058823
Buyback yield (%): 0
Retained earnings: -40698083.82352941
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -56.9400633956467
Rule of 40 score: 0
Financial ratios for WEX.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -6983.333333333333
Operating income: -3467094.696969697
Net income: -3445043.1818181816
Capital expenditures: 5164.393939393939
Operating cash flow: -2931321.212121212
Depreciation & amortization: 6983.333333333333
Net tangible assets: 6039199.242424242
Owner earnings: -3443224.242424242
Return on net tangible assets (%): -57.01458263268145
Buffett classification: The Gruesome
Stock price: 0.5681818181818181
Shares outstanding: 62427269
Book value: 6039199.242424242
P/B ratio: 5.873301704533124
Market cap (USD): 35470039.20454545
Debt to equity: 0
Current ratio: 2.89930301838008
Quick ratio: 2.89930301838008
Free cash flow (dilution-adjusted): -3297790.1515151514
Buyback yield (%): 0
Retained earnings: -45376402.27272727
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -50.57898382169661
Rule of 40 score: 0
Financial ratios for WEX.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 1179.2592592592591
Buffett classification: The Gruesome
Stock price: 0.874074074074074
Shares outstanding: 62427269
Market cap (USD): 54566057.348148145
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WEX.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 1113.986013986014
Buffett classification: The Gruesome
Stock price: 0.6433566433566434
Shares outstanding: 62427269
Market cap (USD): 40162998.23776224
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WEX.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -4454.545454545455
Operating income: -4099639.8601398603
Net income: -3997834.265734266
Capital expenditures: 0
Operating cash flow: -3776053.146853147
Depreciation & amortization: 4454.545454545455
Net tangible assets: 5943527.972027972
Owner earnings: -3993379.7202797206
Return on net tangible assets (%): -67.18870911475078
Buffett classification: The Gruesome
Stock price: 0.6433566433566434
Shares outstanding: 62427269
Book value: 5943527.972027972
P/B ratio: 6.757434040317699
Market cap (USD): 40162998.23776224
Debt to equity: 0
Current ratio: 8.695441581823685
Quick ratio: 8.695441581823685
Free cash flow (dilution-adjusted): -4131926.5734265735
Buyback yield (%): 0
Retained earnings: -45883744.055944055
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -61.48453894553405
Rule of 40 score: 0
Financial ratios for WEX.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -1104.8951048951049
Operating income: -534866.4335664336
Net income: -517998.60139860143
Capital expenditures: 0
Operating cash flow: -368447.55244755244
Depreciation & amortization: 1104.8951048951049
Net tangible assets: 5465678.321678322
Owner earnings: -516893.7062937063
Return on net tangible assets (%): -9.457082467578992
Buffett classification: The Gruesome
Stock price: 0.5734265734265734
Shares outstanding: 62427269
Book value: 5465678.321678322
P/B ratio: 6.549499045537825
Market cap (USD): 35797454.951048955
Debt to equity: 0
Current ratio: 0.7816297590134462
Quick ratio: 0.7816297590134462
Free cash flow (dilution-adjusted): -406669.23076923075
Buyback yield (%): 0
Retained earnings: -46401742.65734266
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.086198300246942
Rule of 40 score: 0
Financial ratios for WEX.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -1162.0437956204378
Operating income: -593916.7883211678
Net income: -595389.7810218978
Capital expenditures: 0
Operating cash flow: -524642.3357664233
Depreciation & amortization: 1162.0437956204378
Net tangible assets: 7624629.197080292
Owner earnings: -594227.7372262774
Return on net tangible assets (%): -7.7935296506461675
Buffett classification: The Gruesome
Stock price: 0.46715328467153283
Shares outstanding: 62427269
Book value: 7624629.197080292
P/B ratio: 3.8248553487152948
Market cap (USD): 29163103.766423356
Debt to equity: 0
Current ratio: 9.165600069154557
Quick ratio: 9.165600069154557
Free cash flow (dilution-adjusted): -566448.905109489
Buyback yield (%): 0
Retained earnings: -49029325.54744525
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.079009290533045
Rule of 40 score: 0
Financial ratios for WEX.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -1303.5971223021584
Operating income: -1168668.3453237412
Net income: -1158410.071942446
Capital expenditures: 0
Operating cash flow: -1160741.726618705
Depreciation & amortization: 1303.5971223021584
Net tangible assets: 6348302.158273382
Owner earnings: -1157106.474820144
Return on net tangible assets (%): -18.227022690029848
Buffett classification: The Gruesome
Stock price: 0.6330935251798562
Shares outstanding: 62427269
Book value: 6348302.158273382
P/B ratio: 6.225648813368782
Market cap (USD): 39522299.798561156
Debt to equity: 0
Current ratio: 5.201732163983334
Quick ratio: 5.201732163983334
Free cash flow (dilution-adjusted): -1191786.330935252
Buyback yield (%): 0
Retained earnings: -49482277.69784173
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.443785390171804
Rule of 40 score: 0
Financial ratios for WEX.V — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -5289.05109489051
Operating income: -2710661.313868613
Net income: -2683714.598540146
Capital expenditures: 5764.233576642336
Operating cash flow: -2770048.905109489
Depreciation & amortization: 5289.05109489051
Net tangible assets: 5990464.963503649
Owner earnings: -2684189.7810218977
Return on net tangible assets (%): -44.80770353178049
Buffett classification: The Gruesome
Stock price: 0.45985401459854014
Shares outstanding: 62427269
Book value: 5990464.963503649
P/B ratio: 4.792187325185998
Market cap (USD): 28707430.270072993
Debt to equity: 0
Current ratio: 2.6136325674622327
Quick ratio: 2.6136325674622327
Free cash flow (dilution-adjusted): -2897633.5766423354
Buyback yield (%): 0
Retained earnings: -50576965.693430655
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -41.64473096208301
Rule of 40 score: 0
Financial ratios for WEX.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -1651.0948905109487
Operating income: -372724.0875912408
Net income: -372318.9781021898
Capital expenditures: 0
Operating cash flow: -683135.7664233577
Depreciation & amortization: 1651.0948905109487
Net tangible assets: 5990464.963503649
Owner earnings: -370667.8832116788
Return on net tangible assets (%): -6.1876312685232016
Buffett classification: The Gruesome
Stock price: 0.45985401459854014
Shares outstanding: 62427269
Book value: 5990464.963503649
P/B ratio: 4.792187325185998
Market cap (USD): 28707430.270072993
Debt to equity: 0
Current ratio: 2.6136325674622327
Quick ratio: 2.6136325674622327
Free cash flow (dilution-adjusted): -697520.4379562044
Buyback yield (%): 0
Retained earnings: -50576965.693430655
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.7262758247995
Rule of 40 score: 0
Financial ratios for XXII — annual report dated 2022-12-31
Total revenue: 40501000
Gross profit: 1847000
Operating income: -33962000
Net income: -59801000
Capital expenditures: 3248000
Operating cash flow: -51714000
Depreciation & amortization: 3591000
Net tangible assets: 88763000
Owner earnings: -59458000
Return on net tangible assets (%): -66.98511767290425
Buffett classification: The Gruesome
Shares outstanding: 345124
Book value: 95975000
Debt to equity: 0.03126855952070852
Current ratio: 3.4264095867260718
Quick ratio: 2.867952066369642
Interest coverage ratio: -617.4909090909091
COGS to revenue (%): 95.43961877484507
R&D to revenue (%): 8.834349769141504
SG&A to revenue (%): 79.58075109256562
Free cash flow (dilution-adjusted): -61632000
Retained earnings: -237814000
Inventory turnover: 5.316918844566713
Receivables turnover: 29.714600146735144
Capitalized R&D asset: 3578000
ROCI (R&D-adjusted, %): -30.012704628476744
FCF margin (%): -152.17402039455817
Rule of 40 score: -152.17402039455817
Financial ratios for XXII — annual report dated 2023-12-31
Total revenue: 32204000
Gross profit: -8696000
Operating income: -42404000
Net income: -140775000
Capital expenditures: 873000
Operating cash flow: -54987000
Depreciation & amortization: 4859000
Net tangible assets: -14334000
Owner earnings: -136789000
Buffett classification: The Gruesome
Stock price: 2772144
Shares outstanding: 345124
Book value: -8410000
Market cap (USD): 956733425856
Debt to equity: -1.9474435196195006
Current ratio: 0.6501957338020292
Quick ratio: 0.47659183510425823
Interest coverage ratio: -4.527439675421738
COGS to revenue (%): 77.29164078996398
R&D to revenue (%): 8.210160228543039
SG&A to revenue (%): 96.46006707241337
Free cash flow (dilution-adjusted): -63283000
Buyback yield (%): 1.86049734638195e-05
Retained earnings: -378707000
Inventory turnover: 5.727335480901979
Receivables turnover: 8.772541541814219
Capitalized R&D asset: 5041260
ROCI (R&D-adjusted, %): -557.0246569359782
Rosenberg metric: -2.946618222470654
FCF margin (%): -196.50664513725002
Revenue growth (%): -20.485913928051158
Rule of 40 score: -216.99255906530118
Financial ratios for XXII — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 200272.5
Shares outstanding: 345124
Market cap (USD): 69118846290
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XXII — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36639
Shares outstanding: 345124
Market cap (USD): 12644998236
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XXII — annual report dated 2024-12-31
Total revenue: 24382000
Gross profit: -2400000
Operating income: -13820000
Net income: -15164000
Capital expenditures: 119000
Operating cash flow: -14345000
Depreciation & amortization: 1258000
Net tangible assets: -1712000
Owner earnings: -14025000
Buffett classification: The Gruesome
Stock price: 36639
Shares outstanding: 345124
Book value: 4012000
P/B ratio: 3151.7941764705884
Market cap (USD): 12644998236
Debt to equity: 2.1478065802592226
Current ratio: 1.1565950612326843
Quick ratio: 0.9543264404738004
Interest coverage ratio: -6.599808978032474
COGS to revenue (%): 58.55959314248216
R&D to revenue (%): 4.646870642277089
SG&A to revenue (%): 42.190960544664094
Free cash flow (dilution-adjusted): -14886000
Buyback yield (%): 0
Retained earnings: -393871000
Inventory turnover: 7.085856079404467
Receivables turnover: 11.092811646951775
Capitalized R&D asset: 4085220
ROCI (R&D-adjusted, %): -95.83727414955392
Rosenberg metric: 2.3812405446293496
FCF margin (%): -61.053235993765895
Revenue growth (%): -24.28890821016023
Rule of 40 score: -85.34214420392613
Financial ratios for XXII — quarterly report dated 2025-03-31
Total revenue: 5956000
Gross profit: -609000
Operating income: -2570000
Net income: -4328000
Capital expenditures: 10000
Operating cash flow: -2976000
Depreciation & amortization: 291000
Net tangible assets: -2489000
Owner earnings: -4047000
Buffett classification: The Gruesome
Stock price: 9936
Shares outstanding: 345124
Book value: 3625000
P/B ratio: 945.9729831724138
Market cap (USD): 3429152064
Debt to equity: 1.534896551724138
Current ratio: 0.6766894364479141
Quick ratio: 0.5208587460356184
Interest coverage ratio: -4.60573476702509
COGS to revenue (%): 48.42175957018133
R&D to revenue (%): 2.719946272666219
SG&A to revenue (%): 30.204835460040297
Free cash flow (dilution-adjusted): -3061000
Buyback yield (%): 0
Retained earnings: -398199000
Inventory turnover: 1.1287671232876713
Receivables turnover: 1.3780657103192966
Capitalized R&D asset: 162000
ROCI (R&D-adjusted, %): -47.12863705972435
FCF margin (%): -51.393552719946264
Rule of 40 score: -51.393552719946264
Financial ratios for XXII — quarterly report dated 2025-06-30
Total revenue: 4083000
Gross profit: -635000
Operating income: -2981000
Net income: -3407000
Capital expenditures: 741000
Operating cash flow: -3478000
Depreciation & amortization: 304000
Net tangible assets: -799000
Owner earnings: -3844000
Buffett classification: The Gruesome
Stock price: 2259
Shares outstanding: 345124
Book value: 5630000
P/B ratio: 138.47870621669628
Market cap (USD): 779635116
Debt to equity: 0.9641207815275311
Current ratio: 0.7710999935026964
Quick ratio: 0.6084724839191735
Interest coverage ratio: -8.492877492877493
COGS to revenue (%): 70.1200097967181
R&D to revenue (%): 5.559637521430321
SG&A to revenue (%): 51.89811413176586
Free cash flow (dilution-adjusted): -3624000
Buyback yield (%): 0
Retained earnings: -401606000
Inventory turnover: 1.1438274071114662
Receivables turnover: 1.1533898305084747
Capitalized R&D asset: 335540
ROCI (R&D-adjusted, %): -39.35381678798978
Rosenberg metric: -0.16049382716049382
FCF margin (%): -88.7582659808964
Revenue growth (%): -31.447280053727333
Rule of 40 score: -120.20554603462372
Financial ratios for XXII — quarterly report dated 2025-09-30
Total revenue: 4011000
Gross profit: -1059000
Operating income: -3212000
Net income: 5489000
Capital expenditures: 6000
Operating cash flow: -4018000
Depreciation & amortization: 305000
Net tangible assets: 14894000
Owner earnings: 5788000
Return on net tangible assets (%): 38.86128642406338
Buffett classification: The Gruesome
Stock price: 507
P/E ratio: 7.969478411368191
Shares outstanding: 345124
Book value: 21104000
P/B ratio: 8.291218157695225
Market cap (USD): 174977868
Debt to equity: 0.055676648976497344
Current ratio: 2.1738264580369844
Quick ratio: 1.8982456140350876
Interest coverage ratio: -6.01498127340824
COGS to revenue (%): 63.7496883570182
R&D to revenue (%): 4.8117676389927695
SG&A to revenue (%): 46.098229867863374
Free cash flow (dilution-adjusted): -4132000
Buyback yield (%): 0
Retained earnings: -396117000
Inventory turnover: 0.8799036476256022
Receivables turnover: 1.3401269629134647
Capitalized R&D asset: 398550
ROCI (R&D-adjusted, %): -14.459588084003322
Rosenberg metric: -1.86784140969163
FCF margin (%): -103.01670406382448
Revenue growth (%): -1.763409257898604
Rule of 40 score: -104.78011332172308
Financial ratios for XXII — quarterly report dated 2025-12-31
Total revenue: 3537000
Gross profit: -834000
Operating income: -2653000
Net income: -2808000
Capital expenditures: 16000
Operating cash flow: 2749000
Depreciation & amortization: 257000
Net tangible assets: 9534000
Owner earnings: -2567000
Return on net tangible assets (%): -26.92469058107825
Buffett classification: The Gruesome
Stock price: 231
Shares outstanding: 345124
Book value: 15758000
P/B ratio: 5.059248889452976
Market cap (USD): 79723644
Debt to equity: 0.0937301688031476
Current ratio: 2.4245049504950495
Quick ratio: 1.8296204620462047
Interest coverage ratio: -221.08333333333334
COGS to revenue (%): 53.20893412496466
R&D to revenue (%): 2.9686174724342664
SG&A to revenue (%): 51.5973989256432
Free cash flow (dilution-adjusted): 1798000
Buyback yield (%): 0
Retained earnings: -398925000
Inventory turnover: 0.4350439204808137
Receivables turnover: 0.9841402337228714
Capitalized R&D asset: 309220
ROCI (R&D-adjusted, %): -13.574128299689633
Rosenberg metric: 1.16580310880829
FCF margin (%): 50.83404014701725
Revenue growth (%): -11.81750186985789
Rule of 40 score: 39.016538277159356
Financial ratios for XXII — annual report dated 2025-12-31
Total revenue: 17587000
Gross profit: -3137000
Operating income: -11416000
Net income: -5054000
Capital expenditures: 709000
Operating cash flow: -7723000
Depreciation & amortization: 1157000
Net tangible assets: 9534000
Owner earnings: -4606000
Return on net tangible assets (%): -48.31130690161527
Buffett classification: The Gruesome
Stock price: 231
Shares outstanding: 345124
Book value: 15758000
P/B ratio: 5.059248889452976
Market cap (USD): 79723644
Debt to equity: 0.0937301688031476
Current ratio: 2.4245049504950495
Quick ratio: 1.8296204620462047
Interest coverage ratio: -7.846048109965635
COGS to revenue (%): 57.917780178540966
R&D to revenue (%): 3.9119804400977993
SG&A to revenue (%): 43.16256325695116
Free cash flow (dilution-adjusted): -9019000
Buyback yield (%): 0
Retained earnings: -398925000
Inventory turnover: 2.35460009246417
Receivables turnover: 4.893433500278242
Capitalized R&D asset: 2319630
ROCI (R&D-adjusted, %): -55.35108573399733
Rosenberg metric: -0.6504854368932039
FCF margin (%): -51.282197077386705
Revenue growth (%): -27.868919694856864
Rule of 40 score: -79.15111677224357
Financial ratios for YUMC — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 6750392.464678179
Buffett classification: The Gruesome
Stock price: 47
Shares outstanding: 343105310
Market cap (USD): 16125949570
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for YUMC — annual report dated 2022-12-31
Total revenue: 1374856321.8390806
Gross profit: 205028735.6321839
Operating income: 94540229.88505748
Net income: 68678160.91954023
Capital expenditures: 97557471.26436782
Operating cash flow: 203017241.37931034
Depreciation & amortization: 86494252.87356322
Net tangible assets: 605172413.7931035
Owner earnings: 57614942.52873564
Return on net tangible assets (%): 9.520417853751189
Capex to operating income (%): 103.19148936170212
Buffett classification: The Gruesome
Stock price: 52.06
P/E ratio: 260.0835869720837
Shares outstanding: 343105310
Book value: 1028735632.183908
P/B ratio: 17.363122147018995
Market cap (USD): 17862062438.600002
Debt to equity: 0.33491620111731846
Current ratio: 1.819021237303786
Quick ratio: 1.6265004616805172
Effective tax rate (%): 30.131004366812224
COGS to revenue (%): 85.08726094680739
SG&A to revenue (%): 6.207545198035322
Free cash flow (dilution-adjusted): 99425287.35632184
Buyback yield (%): 0.37483926180785143
Retained earnings: 314798850.57471263
Inventory turnover: 19.525179856115106
Receivables turnover: 40.54661016949153
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.8115942028985526
FCF margin (%): 7.231685651583238
Rule of 40 score: 7.231685651583238
Financial ratios for YUMC — annual report dated 2023-12-31
Total revenue: 1544022503.5161743
Gross profit: 265119549.9296765
Operating income: 159634317.86216596
Net income: 126722925.45710267
Capital expenditures: 99859353.02390999
Operating cash flow: 207172995.7805907
Depreciation & amortization: 63713080.16877637
Net tangible assets: 591842475.3867792
Owner earnings: 90576652.60196906
Return on net tangible assets (%): 15.304182509505704
Capex to operating income (%): 62.55506607929515
Buffett classification: The Good
Stock price: 40.81
P/E ratio: 110.49403768570589
Shares outstanding: 343105310
Book value: 1001265822.7848102
P/B ratio: 13.984425896168142
Market cap (USD): 14002127701.1
Debt to equity: 0.35637027672425897
Current ratio: 1.416597853014038
Quick ratio: 1.241535920726672
Effective tax rate (%): 26.835236541598697
COGS to revenue (%): 82.82929495354345
SG&A to revenue (%): 5.811623246492985
Free cash flow (dilution-adjusted): 98312236.28691983
Buyback yield (%): 0.6157392518024634
Retained earnings: 324894514.7679325
Inventory turnover: 21.44575471698113
Receivables turnover: 38.791519434628974
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.811843063794358
FCF margin (%): 6.367280014574604
Revenue growth (%): 12.304280744827802
Rule of 40 score: 18.671560759402404
Financial ratios for YUMC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 43.87
Shares outstanding: 343105310
Market cap (USD): 15052029949.699999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for YUMC — quarterly report dated 2024-12-31
Total revenue: 355479452.05479455
Gross profit: 48767123.28767123
Operating income: 23013698.630136985
Net income: 17260273.97260274
Capital expenditures: 24931506.84931507
Operating cash flow: 22876712.328767125
Depreciation & amortization: 16575342.465753425
Net tangible assets: 492739726.0273973
Owner earnings: 8904109.589041092
Return on net tangible assets (%): 1.8070614400889622
Capex to operating income (%): 108.33333333333334
Buffett classification: The Gruesome
Stock price: 47.1
P/E ratio: 234.06725939940478
Shares outstanding: 343105310
Book value: 880410958.9041097
P/B ratio: 18.355360002691768
Market cap (USD): 16160260101
Debt to equity: 0.37482495721176284
Current ratio: 1.1800262812089355
Quick ratio: 1.0026281208935612
Effective tax rate (%): 27.64705882352941
COGS to revenue (%): 86.28131021194604
SG&A to revenue (%): 6.011560693641618
Free cash flow (dilution-adjusted): -3287671.2328767125
Buyback yield (%): 0.1627533820534619
Retained earnings: 286164383.56164384
Inventory turnover: 5.528395061728395
Receivables turnover: 8.212025316455698
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9008825526137134
FCF margin (%): -0.9248554913294796
Rule of 40 score: -0.9248554913294796
Financial ratios for YUMC — annual report dated 2024-12-31
Total revenue: 1548356164.3835616
Gross profit: 258904109.5890411
Operating income: 164383561.64383563
Net income: 134246575.34246576
Capital expenditures: 96575342.46575342
Operating cash flow: 194383561.64383563
Depreciation & amortization: 65205479.4520548
Net tangible assets: 492739726.0273973
Owner earnings: 102876712.32876714
Return on net tangible assets (%): 20.87850986933556
Capex to operating income (%): 58.74999999999999
Buffett classification: The Good
Stock price: 47.1
P/E ratio: 120.37744769112246
Shares outstanding: 343105310
Book value: 880410958.9041097
P/B ratio: 18.355360002691768
Market cap (USD): 16160260101
Debt to equity: 0.37482495721176284
Current ratio: 1.1800262812089355
Quick ratio: 1.0026281208935612
Effective tax rate (%): 26.746806912096165
COGS to revenue (%): 83.27877554631515
SG&A to revenue (%): 5.025214544811112
Free cash flow (dilution-adjusted): 92191780.82191782
Buyback yield (%): 1.0587446572123642
Retained earnings: 286164383.56164384
Inventory turnover: 23.241975308641976
Receivables turnover: 35.76898734177215
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.577732518669382
FCF margin (%): 5.954171458904716
Revenue growth (%): 0.2806734265542327
Rule of 40 score: 6.234844885458949
Financial ratios for YUMC — quarterly report dated 2025-03-31
Total revenue: 410606060.6060606
Gross profit: 78787878.7878788
Operating income: 55785123.966942154
Net income: 43112947.658402205
Capital expenditures: 18870523.415977962
Operating cash flow: 62258953.168044075
Depreciation & amortization: 15013774.104683196
Net tangible assets: 501790633.60881543
Owner earnings: 39256198.34710744
Return on net tangible assets (%): 7.823222618720835
Capex to operating income (%): 33.82716049382716
Buffett classification: The Good
Stock price: 51.15
P/E ratio: 101.7666244114936
Shares outstanding: 343105310
Book value: 886914600.5509642
P/B ratio: 19.787515726539834
Market cap (USD): 17549836606.5
Debt to equity: 0.3680695760211212
Current ratio: 1.2557077625570778
Quick ratio: 1.1054794520547948
Effective tax rate (%): 27.80373831775701
COGS to revenue (%): 80.81180811808117
SG&A to revenue (%): 4.6293190204629315
Free cash flow (dilution-adjusted): 42148760.33057852
Buyback yield (%): 0.1357801877944702
Retained earnings: 292561983.4710744
Inventory turnover: 7.322188449848023
Receivables turnover: 10.037037037037036
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.596005447117568
FCF margin (%): 10.265011741026504
Revenue growth (%): 15.507677935423594
Rule of 40 score: 25.7726896764501
Financial ratios for YUMC — quarterly report dated 2025-06-30
Total revenue: 388702928.8702929
Gross profit: 66387726.63877267
Operating income: 43933054.39330544
Net income: 32496513.249651324
Capital expenditures: 17015341.70153417
Operating cash flow: 57461645.746164575
Depreciation & amortization: 15341701.534170154
Net tangible assets: 505160390.5160391
Owner earnings: 30822873.082287308
Return on net tangible assets (%): 6.101601325234677
Capex to operating income (%): 38.73015873015873
Buffett classification: The Good
Stock price: 44.17
P/E ratio: 163.18514920038402
Shares outstanding: 343105310
Book value: 902231520.223152
P/B ratio: 16.797198061703355
Market cap (USD): 15154961542.7
Debt to equity: 0.34472097696707377
Current ratio: 1.387111729253593
Quick ratio: 1.2202132591562356
Effective tax rate (%): 25.72347266881029
COGS to revenue (%): 82.92070326515967
SG&A to revenue (%): 4.700394689630427
Free cash flow (dilution-adjusted): 38633193.86331939
Buyback yield (%): 0.17945708831419396
Retained earnings: 294281729.42817295
Inventory turnover: 6.419444444444445
Receivables turnover: 7.895184135977338
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.569000679809654
FCF margin (%): 9.939002511661284
Revenue growth (%): -5.3343420463493345
Rule of 40 score: 4.60466046531195